메뉴 건너뛰기




Volumn 11, Issue 9, 2006, Pages 359-376

German-Austrian recommendations for HIV-therapy in pregnancy and in HIV-exposed newborn - Update 2005

Author keywords

Anti retroviral drugs; HIV status; HIV testing; HIV therapy; Pregnancy; Recommendations

Indexed keywords

ABACAVIR PLUS LAMIVUDINE; AMPRENAVIR; ANTIRETROVIRUS AGENT; BENZODIAZEPINE DERIVATIVE; DIDANOSINE; EFAVIRENZ; EMTRICITABINE; INDINAVIR; LAMIVUDINE; LAMIVUDINE PLUS ZIDOVUDINE; LOPINAVIR PLUS RITONAVIR; NELFINAVIR; NEVIRAPINE; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; STAVUDINE; TENOFOVIR; ZALCITABINE; ZIDOVUDINE;

EID: 33750064539     PISSN: 09492321     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (17)

References (134)
  • 1
    • 12344262349 scopus 로고    scopus 로고
    • Bundeszentrale für gesundheitliche Aufklärung
    • Köln: Aids von A bis Z; Neuauflage
    • Bundeszentrale für gesundheitliche Aufklärung, Köln: Aids von A bis Z; Neuauflage 2002
    • (2002)
  • 2
    • 33750077642 scopus 로고    scopus 로고
    • Deutsche AIDS-Hilfe e.V.: Der heutige Wissensstand 28
    • überarbeitete Auflage
    • Deutsche AIDS-Hilfe e.V.: Der heutige Wissensstand 28. überarbeitete Auflage, 2002
    • (2002)
  • 3
    • 16944366011 scopus 로고    scopus 로고
    • Maternal Virus Load during Pregnancy and Mother-to-Child Transmission of Human Immunodeficiency Virus Type 1: The French Perinatal Cohort Studies
    • Mayaux MJ, Dussaix E, Isopet J et al.: Maternal Virus Load during Pregnancy and Mother-to-Child Transmission of Human Immunodeficiency Virus Type 1: The French Perinatal Cohort Studies. J Infect Dis 1997; 175: 172-175
    • (1997) J Infect Dis , vol.175 , pp. 172-175
    • Mayaux, M.J.1    Dussaix, E.2    Isopet, J.3
  • 4
    • 10544245018 scopus 로고    scopus 로고
    • Maternal Viral Load, Zidovudine Treatment, and the Risk of Transmission of Human Immunodeficiency Virus Type 1 from Mother to Infant
    • Sperling RS, Shapiro DE, Coombs RW et al.: Maternal Viral Load, Zidovudine Treatment, and the Risk of Transmission of Human Immunodeficiency Virus Type 1 from Mother to Infant. N Engl J Med 1996; 335: 1621-1629
    • (1996) N Engl J Med , vol.335 , pp. 1621-1629
    • Sperling, R.S.1    Shapiro, D.E.2    Coombs, R.W.3
  • 5
    • 0036239507 scopus 로고    scopus 로고
    • Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission
    • Cooper ER, Charurat M, Mofenson L et al.: Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission. JAIDS 2002; 29: 484-494
    • (2002) JAIDS , vol.29 , pp. 484-494
    • Cooper, E.R.1    Charurat, M.2    Mofenson, L.3
  • 6
    • 0038078685 scopus 로고    scopus 로고
    • Long-term mitochondrial toxicity in HIV-uninfected infants born to HIV-infected mothers
    • Poirier MC, Divi RL, Al-Harthi L et al.: Long-term mitochondrial toxicity in HIV-uninfected infants born to HIV-infected mothers. JAIDS 2003; 32: 175-183
    • (2003) JAIDS , vol.32 , pp. 175-183
    • Poirier, M.C.1    Divi, R.L.2    Al-Harthi, L.3
  • 7
    • 0042232027 scopus 로고    scopus 로고
    • Persistent mitochondrial dysfunction in HIV-1-exposed but uninfected infants: Clinical screening in a large prospective cohort
    • Barret B, Tardieu M, Rustin P et al.: Persistent mitochondrial dysfunction in HIV-1-exposed but uninfected infants: clinical screening in a large prospective cohort. AIDS 2003; 17:1769-1785
    • (2003) AIDS , vol.17 , pp. 1769-1785
    • Barret, B.1    Tardieu, M.2    Rustin, P.3
  • 8
    • 0033604060 scopus 로고    scopus 로고
    • Persistent mitochondrial dysfunction and perinatal exposure to anti-retroviral nucleoside analogues
    • Blanche S, Tardieu M, Rustin P et al.: Persistent mitochondrial dysfunction and perinatal exposure to anti-retroviral nucleoside analogues. Lancet 1999; 354: 1084-1089
    • (1999) Lancet , vol.354 , pp. 1084-1089
    • Blanche, S.1    Tardieu, M.2    Rustin, P.3
  • 9
    • 0033572374 scopus 로고    scopus 로고
    • Incorporation of 3′-Azido-3′-Deoxythymidine (AZT) into fetal DNA and fetal tissue distribution of drug after infusion of pregnant late-term rhesus macaques with a human-equivalent AZT dose
    • Poirier MC, Patterson TA, Slikker Jr. W, Olivero OA: Incorporation of 3′-Azido-3′-Deoxythymidine (AZT) into fetal DNA and fetal tissue distribution of drug after infusion of pregnant late-term rhesus macaques with a human-equivalent AZT dose. JAIDS 1999; 22: 477-483
    • (1999) JAIDS , vol.22 , pp. 477-483
    • Poirier, M.C.1    Patterson, T.A.2    Slikker Jr., W.3    Olivero, O.A.4
  • 10
    • 0033731153 scopus 로고    scopus 로고
    • Zidovudine-didanosine coexposure potentiates DNA incorporation of zidovudine and mutagenesis in human cells
    • Meng Q, Walker DM, Olivero OA et al.: Zidovudine-didanosine coexposure potentiates DNA incorporation of zidovudine and mutagenesis in human cells. Proc Natl Acad Sci USA 2000; 97: 12667-12671
    • (2000) Proc Natl Acad Sci USA , vol.97 , pp. 12667-12671
    • Meng, Q.1    Walker, D.M.2    Olivero, O.A.3
  • 11
    • 0031944954 scopus 로고    scopus 로고
    • Severe transient neonatal lactic acidosis during prophylactic zidovudine treatment
    • Scalfaro P, Chesaux JJ, Buchwalder PA et al.: Severe transient neonatal lactic acidosis during prophylactic zidovudine treatment. Intensive Care Med 1998; 24: 247-250
    • (1998) Intensive Care Med , vol.24 , pp. 247-250
    • Scalfaro, P.1    Chesaux, J.J.2    Buchwalder, P.A.3
  • 12
    • 0037379462 scopus 로고    scopus 로고
    • Exposure to antiretroviral therapy in utero or early life: The health of uninfected children born to HIV-infected women
    • European Collaborative Study
    • European Collaborative Study: Exposure to antiretroviral therapy in utero or early life: the health of uninfected children born to HIV-infected women. JAIDS 2003; 32: 380-387
    • (2003) JAIDS , vol.32 , pp. 380-387
  • 13
    • 46149144608 scopus 로고
    • Routinemäßige Gabe von Zidovudin an HIV-infizierte Schwangere
    • Wahn V: Routinemäßige Gabe von Zidovudin an HIV-infizierte Schwangere. Dt Ärztebl 1995; 92:A-3397-3398
    • (1995) Dt Ärztebl , vol.92
    • Wahn, V.1
  • 14
    • 16944361839 scopus 로고    scopus 로고
    • Analysis of the Maternal Components of the AIDS Clinical Trial Group 076 Zidovudine Regimen in the Prevention of Mother-to-Infant Transmission of Human Immunodeficiency Virus Type 1
    • Frenkel LM, Cowles MK, Shapiro DE et al.: Analysis of the Maternal Components of the AIDS Clinical Trial Group 076 Zidovudine Regimen in the Prevention of Mother-to-Infant Transmission of Human Immunodeficiency Virus Type 1. J Infect Dis 1997; 175: 971-974
    • (1997) J Infect Dis , vol.175 , pp. 971-974
    • Frenkel, L.M.1    Cowles, M.K.2    Shapiro, D.E.3
  • 15
    • 0030013531 scopus 로고    scopus 로고
    • Obstetrical Factors and The Transmission of Human Immunodeficiency Virus Type 1 from Mother to Child
    • Landesmann SH, Kalish LA, Burns DN et al.: Obstetrical Factors and The Transmission of Human Immunodeficiency Virus Type 1 from Mother to Child. N Engl J Med 1996; 334:1617-1623
    • (1996) N Engl J Med , vol.334 , pp. 1617-1623
    • Landesmann, S.H.1    Kalish, L.A.2    Burns, D.N.3
  • 16
    • 0032123511 scopus 로고    scopus 로고
    • Perinatal HIV-1 Transmission. Interaction between Zidovudine Prophylaxis and Mode of Delivery in the French Perinatal Cohort
    • Mandelbrot L, Le Chenadec J, Berrebi A et al.: Perinatal HIV-1 Transmission. Interaction between Zidovudine Prophylaxis and Mode of Delivery in the French Perinatal Cohort. JAMA 1998; 280: 55-60
    • (1998) JAMA , vol.280 , pp. 55-60
    • Mandelbrot, L.1    Le Chenadec, J.2    Berrebi, A.3
  • 17
    • 0031017125 scopus 로고    scopus 로고
    • Maternal Immunologic and Virologic Risk Factors for Infant Human Immunodeficiency Virus Type 1 Infection: Findings from the Women and Infants Transmission Study
    • Pitt J, Brambilla D, Reichelderfer P et al.: Maternal Immunologic and Virologic Risk Factors for Infant Human Immunodeficiency Virus Type 1 Infection: Findings from the Women and Infants Transmission Study. J Infect Dis 1997; 175: 567-575
    • (1997) J Infect Dis , vol.175 , pp. 567-575
    • Pitt, J.1    Brambilla, D.2    Reichelderfer, P.3
  • 18
    • 0031954082 scopus 로고    scopus 로고
    • Transport of Viruses Through Fetal Membranes: An In Vitro Model of Perinatal Transmission
    • Rokos K, Wang H, Seeger J et al.: Transport of Viruses Through Fetal Membranes: An In Vitro Model of Perinatal Transmission. J Med Virology 1998; 54: 313-319
    • (1998) J Med Virology , vol.54 , pp. 313-319
    • Rokos, K.1    Wang, H.2    Seeger, J.3
  • 19
    • 0029951260 scopus 로고    scopus 로고
    • Vertical transmission of HIV-1: Maternal immune status and obstetric factors
    • The European Collaborative Study
    • The European Collaborative Study: Vertical transmission of HIV-1: maternal immune status and obstetric factors. AIDS 1996; 10: 1675-1681
    • (1996) AIDS , vol.10 , pp. 1675-1681
  • 20
    • 0030772885 scopus 로고    scopus 로고
    • Immunological markers in HIV-infected pregnant women
    • The European Collaborative Study
    • The European Collaborative Study: Immunological markers in HIV-infected pregnant women. AIDS 1997; 11: 1859-1865
    • (1997) AIDS , vol.11 , pp. 1859-1865
  • 21
    • 0037314746 scopus 로고    scopus 로고
    • Cell-associated genital tract virus and vertical transmission of human immunodeficiency virus type 1 in antiretroviral-experienced women
    • Tuomala RE, O'Driscoll PT, Bremer JW et al.: Cell-associated genital tract virus and vertical transmission of human immunodeficiency virus type 1 in antiretroviral-experienced women. JID 2003; 187: 375-384
    • (2003) JID , vol.187 , pp. 375-384
    • Tuomala, R.E.1    O'Driscoll, P.T.2    Bremer, J.W.3
  • 22
    • 0030898198 scopus 로고    scopus 로고
    • Influence of other maternal variables on the relationship between maternal virus load and mother-to-infant transmission of human immunodeficiency virus type 1
    • Burns DN, Landesman S, Wright, DJ et al.: Influence of other maternal variables on the relationship between maternal virus load and mother-to-infant transmission of human immunodeficiency virus type 1. J Infect Dis 1997; 175:1206-1210
    • (1997) J Infect Dis , vol.175 , pp. 1206-1210
    • Burns, D.N.1    Landesman, S.2    Wright, D.J.3
  • 23
    • 0033764669 scopus 로고    scopus 로고
    • Exposure to HIV-1 during delivery and mother-to-child transmission
    • Gaillard P, Verhofstede C, Mwanyumba F et al.: Exposure to HIV-1 during delivery and mother-to-child transmission. AIDS 2000; 14: 2341-2348
    • (2000) AIDS , vol.14 , pp. 2341-2348
    • Gaillard, P.1    Verhofstede, C.2    Mwanyumba, F.3
  • 24
    • 0035094157 scopus 로고    scopus 로고
    • Human immunodeficiency virus 1 expression in the female genital tract in association with cervical inflammation and ulceration
    • Wright TC Jr, Subbarao S, Ellerbrock TV et al.: Human immunodeficiency virus 1 expression in the female genital tract in association with cervical inflammation and ulceration. Am J Obstet Gynecol. 2001; 184: 279-285
    • (2001) Am J Obstet Gynecol. , vol.184 , pp. 279-285
    • Wright Jr., T.C.1    Subbarao, S.2    Ellerbrock, T.V.3
  • 25
    • 0036499954 scopus 로고    scopus 로고
    • Placental inflammation and perinatal transmission of HIV-1
    • Mwanyumba F, Gaillard P, Inion I et al.: Placental inflammation and perinatal transmission of HIV-1. JAIDS 2002; 29: 262-269
    • (2002) JAIDS , vol.29 , pp. 262-269
    • Mwanyumba, F.1    Gaillard, P.2    Inion, I.3
  • 26
    • 0032556960 scopus 로고    scopus 로고
    • Prevention of vertical HIV transmission: Additive protective effect of elective Cesarean section and zidovudine prophylaxis
    • Kind Ch, Rudin Ch, Siegrist C et al.: Prevention of vertical HIV transmission: additive protective effect of elective Cesarean section and zidovudine prophylaxis. AIDS 1998; 12: 205-210
    • (1998) AIDS , vol.12 , pp. 205-210
    • Kind, C.H.1    Rudin, C.H.2    Siegrist, C.3
  • 27
    • 0029876109 scopus 로고    scopus 로고
    • Die HIV-Infektion in Geburtshilfe und Gynäkologie
    • Schäfer APA: Die HIV-Infektion in Geburtshilfe und Gynäkologie. Gynäkologe 1996; 29:129-137
    • (1996) Gynäkologe , vol.29 , pp. 129-137
    • Schäfer, A.P.A.1
  • 28
    • 33750040595 scopus 로고    scopus 로고
    • Influence of cesarean section before parturition and antiretroviral prophylaxis on the materno-fetal transmission of HIV
    • 12th World AIDS Conference Geneva, June 28-July 3 Poster LB 12466
    • Schäfer A, Friese K, Lauper U et al.: Influence of cesarean section before parturition and antiretroviral prophylaxis on the materno-fetal transmission of HIV. 12th World AIDS Conference Geneva, June 28-July 3 1998, Poster LB 12466
    • (1998)
    • Schäfer, A.1    Friese, K.2    Lauper, U.3
  • 29
    • 13844312888 scopus 로고    scopus 로고
    • German-Austrian recommendations for the antiretroviral therapy of HIV-infection (status May 2004)
    • URL: unter Leithnien
    • Salzberger B, Marcus U, Vielhaber B et al.: German-Austrian recommendations for the antiretroviral therapy of HIV-infection (status May 2004). Eur J Med Res. 2004; 9(11): 491-504 URL: http:// www.daignet.de unter Leithnien
    • (2004) Eur J Med Res. , vol.9 , Issue.11 , pp. 491-504
    • Salzberger, B.1    Marcus, U.2    Vielhaber, B.3
  • 30
    • 0012565358 scopus 로고    scopus 로고
    • Pregnancy and HIV infection: A european consensus on management
    • Coll O, Fiore S, Floridia M et al.: Pregnancy and HIV infection: A european consensus on management. AIDS 2002; 16 (Suppl 2): S1-18
    • (2002) AIDS , vol.16 , Issue.SUPPL. 2
    • Coll, O.1    Fiore, S.2    Floridia, M.3
  • 31
    • 0003176164 scopus 로고    scopus 로고
    • Recommendations for the Use of Antiretroviral Drugs in Pregnant Women Infected with HIV-1 for Maternal Health and for Reducing Perinatal HIV-1 Transmission in the United States
    • CDC Public Health Service Task Force 47/RR2
    • CDC Public Health Service Task Force: Recommendations for the Use of Antiretroviral Drugs in Pregnant Women Infected with HIV-1 for Maternal Health and for Reducing Perinatal HIV-1 Transmission in the United States. MMWR 1998; 47/RR2
    • (1998) MMWR
  • 32
    • 4243522918 scopus 로고    scopus 로고
    • Report of the NIH Panel to Define Principles of Therapy of HIV Infection and Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents
    • CDC 47/RR-5
    • CDC: Report of the NIH Panel to Define Principles of Therapy of HIV Infection and Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents. MMWR 1998; 47/RR-5
    • (1998) MMWR
  • 33
    • 0037340734 scopus 로고    scopus 로고
    • Protease inhibitor use and the incidence of diabetes mellitus in a large cohort of HIV-infected women
    • Justman JE, Benning L, Danoff A et al.: Protease inhibitor use and the incidence of diabetes mellitus in a large cohort of HIV-infected women. JAIDS 2003; 32: 298-302
    • (2003) JAIDS , vol.32 , pp. 298-302
    • Justman, J.E.1    Benning, L.2    Danoff, A.3
  • 34
    • 0032564576 scopus 로고    scopus 로고
    • Antiretroviral therapies in pregnancy: Maternal, fetal and neonatal effects
    • (Swiss HIV Cohort Study, the Swiss Collaborative HIV and Pregnancy Study, and the Swiss Neonatal HIV Study)
    • Lorenzi P, Spicher VM, Laubereau B et al. (Swiss HIV Cohort Study, the Swiss Collaborative HIV and Pregnancy Study, and the Swiss Neonatal HIV Study): Antiretroviral therapies in pregnancy: maternal, fetal and neonatal effects. AIDS 1998; 12 (18): F 241-247
    • (1998) AIDS , vol.12 , Issue.18
    • Lorenzi, P.1    Spicher, V.M.2    Laubereau, B.3
  • 35
    • 0037068948 scopus 로고    scopus 로고
    • Pre-eclampsia, antiretroviral therapy, and immune reconstitution
    • Wimalasundera RC, Larbalestier N, Smith JH et al.: Pre-eclampsia, antiretroviral therapy, and immune reconstitution. Lancet 2002, 360: 1152-1154
    • (2002) Lancet , vol.360 , pp. 1152-1154
    • Wimalasundera, R.C.1    Larbalestier, N.2    Smith, J.H.3
  • 36
    • 0037071791 scopus 로고    scopus 로고
    • Antiretroviral therapy during pregnancy and the risk of an adverse outcome
    • Tuomala RE, Shapiro DE, Mofenson LM et al.: Antiretroviral therapy during pregnancy and the risk of an adverse outcome. N Engl J Med 2002; 346:1863-1870
    • (2002) N Engl J Med , vol.346 , pp. 1863-1870
    • Tuomala, R.E.1    Shapiro, D.E.2    Mofenson, L.M.3
  • 37
    • 0037065567 scopus 로고    scopus 로고
    • HIV-1 infection and risk of vulvovaginal and perianal condylomata acuminata and intraepithelial neoplasia: A prospective cohort study
    • Conley LJ, Ellerbrock TV, Bush TJ et al.: HIV-1 infection and risk of vulvovaginal and perianal condylomata acuminata and intraepithelial neoplasia: a prospective cohort study. Lancet 2002; 359: 108-113
    • (2002) Lancet , vol.359 , pp. 108-113
    • Conley, L.J.1    Ellerbrock, T.V.2    Bush, T.J.3
  • 38
    • 19944403922 scopus 로고    scopus 로고
    • Updated European recommendations for the clinical use of HIV drug resistance testing
    • Vandamme AM, Sonnerborg A, Ait-Khaled M et al.: Updated European recommendations for the clinical use of HIV drug resistance testing. Antivir Ther 2004; 9(6): 829-848
    • (2004) Antivir Ther , vol.9 , Issue.6 , pp. 829-848
    • Vandamme, A.M.1    Sonnerborg, A.2    Ait-Khaled, M.3
  • 39
    • 0034105783 scopus 로고    scopus 로고
    • HIV-1 genotypic zidovudine drug resistance and the risk of maternal-infant transmission in the Women and Infants Transmission Study
    • The Women and Infants Transmission Study Group
    • Welles SL, Pitt J, Colgrove R and The Women and Infants Transmission Study Group: HIV-1 genotypic zidovudine drug resistance and the risk of maternal-infant transmission in the Women and Infants Transmission Study. AIDS 2000; 14:263-271
    • (2000) AIDS , vol.14 , pp. 263-271
    • Welles, S.L.1    Pitt, J.2    Colgrove, R.3
  • 40
    • 0035280397 scopus 로고    scopus 로고
    • Frequency of genotypic and phenotypic drug-resistant HIV-1 among therapy-naive patients of the German Seroconverter Study
    • Duwe S, Brunn M, Altmann D et al.: Frequency of genotypic and phenotypic drug-resistant HIV-1 among therapy-naive patients of the German Seroconverter Study. JAIDS 2001; 26: 266-273
    • (2001) JAIDS , vol.26 , pp. 266-273
    • Duwe, S.1    Brunn, M.2    Altmann, D.3
  • 41
    • 0031912007 scopus 로고    scopus 로고
    • Maternal Viral Genotypic Zidovudine Resistance and Infrequent Zidovudine Therapy to Prevent Perinatal Transmission of Human Immunodeficiency Virus Type 1 in Pediatric Clinical Trial Protocol 076
    • Eastman PS, Shapiro DE, Coombs RW et al.: Maternal Viral Genotypic Zidovudine Resistance and Infrequent Zidovudine Therapy to Prevent Perinatal Transmission of Human Immunodeficiency Virus Type 1 in Pediatric Clinical Trial Protocol 076. J Infect Dis 1998; 177: 557-564
    • (1998) J Infect Dis , vol.177 , pp. 557-564
    • Eastman, P.S.1    Shapiro, D.E.2    Coombs, R.W.3
  • 42
    • 0035946701 scopus 로고    scopus 로고
    • Lamivudine-Zidovudine combination for prevention of maternal-infant transmission of HIV-1
    • Mandelbrot L, Landreau-Mascaro A, Rekacewicz C et al.: Lamivudine-Zidovudine combination for prevention of maternal-infant transmission of HIV-1. JAMA 2001; 285: 2083-2093
    • (2001) JAMA , vol.285 , pp. 2083-2093
    • Mandelbrot, L.1    Landreau-Mascaro, A.2    Rekacewicz, C.3
  • 43
    • 0033816265 scopus 로고    scopus 로고
    • Identification of the K103N resistance mutation in Ugandan women receiving nevirapine to prevent HIV-1 vertical transmission
    • Jackson JB, Becker-Pergola G, Guay LA et al.: Identification of the K103N resistance mutation in Ugandan women receiving nevirapine to prevent HIV-1 vertical transmission. AIDS 2000; 14: F111-F115
    • (2000) AIDS , vol.14
    • Jackson, J.B.1    Becker-Pergola, G.2    Guay, L.A.3
  • 44
    • 20844453585 scopus 로고    scopus 로고
    • Nevirapine (NVP) resistance in women with HIV-1 subtype C, compared with subtypes A and D, after the administration of single-dose NVP
    • Eshleman SH, Hoover DR, Chen S et al.: Nevirapine (NVP) resistance in women with HIV-1 subtype C, compared with subtypes A and D, after the administration of single-dose NVP. J Infect Dis 2005; 192(1): 30-36
    • (2005) J Infect Dis , vol.192 , Issue.1 , pp. 30-36
    • Eshleman, S.H.1    Hoover, D.R.2    Chen, S.3
  • 45
    • 33750073583 scopus 로고    scopus 로고
    • Sustiva Capsules Product Monograph
    • Sustiva Capsules Product Monograph 1998
    • (1998)
  • 46
    • 33750063699 scopus 로고    scopus 로고
    • BMS Warning Letter, 5. January
    • BMS Warning Letter, 5. January 2001
    • (2001)
  • 47
    • 0028970597 scopus 로고
    • CD4+ lymphocytes in perinatal human immunodeficiency virus (HIV) infection: Evidence for pregnancy-induced immune depression in uninfected and HIV-infected women
    • Rich KC, Siegel JN, Jennings C et al.: CD4+ lymphocytes in perinatal human immunodeficiency virus (HIV) infection: evidence for pregnancy-induced immune depression in uninfected and HIV-infected women. J Infect Dis 1995; 172: 1221-1227
    • (1995) J Infect Dis , vol.172 , pp. 1221-1227
    • Rich, K.C.1    Siegel, J.N.2    Jennings, C.3
  • 48
    • 0037867606 scopus 로고    scopus 로고
    • Pharmacokinetics of nelfinavir and indinavir in HIV-1-infected pregnant women
    • Kosel BW, Beckerman KP, Hayashi S et al.: Pharmacokinetics of nelfinavir and indinavir in HIV-1-infected pregnant women. AIDS 2003; 17:1195-1199
    • (2003) AIDS , vol.17 , pp. 1195-1199
    • Kosel, B.W.1    Beckerman, K.P.2    Hayashi, S.3
  • 49
    • 17344368990 scopus 로고    scopus 로고
    • Pharmacokinetics of nevirapine in human immunodeficiency virus type 1-infected pregnant women and their neonates. Pediatric AIDS Clinical Trials Group Protocol 250 Team
    • Mirochnick M, Fenton T, Gagnier P et al.: Pharmacokinetics of nevirapine in human immunodeficiency virus type 1-infected pregnant women and their neonates. Pediatric AIDS Clinical Trials Group Protocol 250 Team. J Infect Dis 1998; 178: 368-374
    • (1998) J Infect Dis , vol.178 , pp. 368-374
    • Mirochnick, M.1    Fenton, T.2    Gagnier, P.3
  • 50
    • 0032728821 scopus 로고    scopus 로고
    • Pharmacokinetics of didanosine in antepartum and postpartum human immunodeficiency virus-infected pregnant women and their neonates: An AIDS clinical trials group study
    • Wang Y, Livingston E, Patil S, et al.: Pharmacokinetics of didanosine in antepartum and postpartum human immunodeficiency virus-infected pregnant women and their neonates: an AIDS clinical trials group study. J Infect Dis 1999; 180: 1536-1541
    • (1999) J Infect Dis , vol.180 , pp. 1536-1541
    • Wang, Y.1    Livingston, E.2    Patil, S.3
  • 51
    • 0028144849 scopus 로고
    • Metabolism of 3′-Azido-3′-Deoxythymidine (AZT) in Human Placental Trophophlasts and Hofbauer Cells
    • Qian M, Bui T, Ho RJY et al.: Metabolism of 3′-Azido-3′-Deoxythymidine (AZT) in Human Placental Trophophlasts and Hofbauer Cells. Biochemical Pharmacology 1994; 48: 383-389
    • (1994) Biochemical Pharmacology , vol.48 , pp. 383-389
    • Qian, M.1    Bui, T.2    Ho, R.J.Y.3
  • 52
    • 0037446447 scopus 로고    scopus 로고
    • Phosphorylation of 3′-Azidothymidine in maternal and fetal peripheral blood mononuclear cells during gestation and and at term
    • Agbaria R, Manor E, Barak J et al.: Phosphorylation of 3′-Azidothymidine in maternal and fetal peripheral blood mononuclear cells during gestation and and at term. JAIDS 2003; 32: 477-481
    • (2003) JAIDS , vol.32 , pp. 477-481
    • Agbaria, R.1    Manor, E.2    Barak, J.3
  • 53
    • 0034679252 scopus 로고    scopus 로고
    • Pharmacological implications of lengthened in-utero exposure to nevirapine
    • Taylor GP, Lyall EGH, Back D et al.: Pharmacological implications of lengthened in-utero exposure to nevirapine. Lancet 2000; 355: 2134-2135
    • (2000) Lancet , vol.355 , pp. 2134-2135
    • Taylor, G.P.1    Lyall, E.G.H.2    Back, D.3
  • 54
    • 0037066372 scopus 로고    scopus 로고
    • Transplacental passage of protease inhibitors at delivery
    • Marzolini C, Rudin C, Decosterd LA et al.: Transplacental passage of protease inhibitors at delivery. AIDS 2002; 16: 889-893
    • (2002) AIDS , vol.16 , pp. 889-893
    • Marzolini, C.1    Rudin, C.2    Decosterd, L.A.3
  • 55
    • 0036375115 scopus 로고    scopus 로고
    • Concentrations of protease inhibitors in cord blood after in utero exposure
    • Mirochnick M, Dorenbaum A, Holland D et al.: Concentrations of protease inhibitors in cord blood after in utero exposure. Pediatr Infect Dis J 2002; 21 (9): 835-838
    • (2002) Pediatr Infect Dis J , vol.21 , Issue.9 , pp. 835-838
    • Mirochnick, M.1    Dorenbaum, A.2    Holland, D.3
  • 56
    • 0038417259 scopus 로고    scopus 로고
    • Predose infant nevirapine concentration with the two-dose intrapartum neonatal nevirapine regimen: Association with timing of maternal intrapartum nevirapine dose
    • Mirochnick M, Dorenbaum A, Blanchard S et al.: Predose infant nevirapine concentration with the two-dose intrapartum neonatal nevirapine regimen: association with timing of maternal intrapartum nevirapine dose. JAIDS 2003; 33(2): 153-156
    • (2003) JAIDS , vol.33 , Issue.2 , pp. 153-156
    • Mirochnick, M.1    Dorenbaum, A.2    Blanchard, S.3
  • 58
  • 60
    • 0003922888 scopus 로고    scopus 로고
    • Arzneiverordnung in Schwangerschaft und Stillzeit
    • 5. Aufl., Stuttgart, Gustav Fischer
    • Spielmann H, Steinhoff R, Schaefer C et al.: Arzneiverordnung in Schwangerschaft und Stillzeit. 5. Aufl., Stuttgart, Gustav Fischer, 1998
    • (1998)
    • Spielmann, H.1    Steinhoff, R.2    Schaefer, C.3
  • 61
    • 0028003766 scopus 로고
    • Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine Treatment
    • Connor EM, Sperling RS, Gelber R et al.: Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine Treatment. N Engl J Med 1994; 331:1173-1180
    • (1994) N Engl J Med , vol.331 , pp. 1173-1180
    • Connor, E.M.1    Sperling, R.S.2    Gelber, R.3
  • 62
    • 0242289041 scopus 로고    scopus 로고
    • Short-course antenatal zidovudine reduces both cervicovaginal human immunodeficiency virus type 1 RNA levels and risk of perinatal transmission
    • Chuachoowong R, Shaffer N, Siriwasin W et al.: Short-course antenatal zidovudine reduces both cervicovaginal human immunodeficiency virus type 1 RNA levels and risk of perinatal transmission. J Inf Dis 2000; 181: 99-106
    • (2000) J Inf Dis , vol.181 , pp. 99-106
    • Chuachoowong, R.1    Shaffer, N.2    Siriwasin, W.3
  • 63
    • 0034610026 scopus 로고    scopus 로고
    • A trial of shortened zidovudine regimens to prevent mother-to-child transmission of human immunodeficiency virus type 1
    • Lallemant M, Jourdain G, Le Coeur S et al.: A trial of shortened zidovudine regimens to prevent mother-to-child transmission of human immunodeficiency virus type 1. N Eng J Med 2000; 343: 982-991
    • (2000) N Eng J Med , vol.343 , pp. 982-991
    • Lallemant, M.1    Jourdain, G.2    Le Coeur, S.3
  • 64
    • 0032511952 scopus 로고    scopus 로고
    • Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus
    • Wade NA, Birkhead GS, Warren BL et al.: Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus. N Engl J Med 1998; 339: 1409-1414
    • (1998) N Engl J Med , vol.339 , pp. 1409-1414
    • Wade, N.A.1    Birkhead, G.S.2    Warren, B.L.3
  • 65
    • 0038128513 scopus 로고    scopus 로고
    • Short-term effect of zidovudine on plasma and genital human immunodeficiency virus type 1 and viral turnover in these compartments
    • Mbori-Ngacha D, Richardson BA, Overbaugh J et al.: Short-term effect of zidovudine on plasma and genital human immunodeficiency virus type 1 and viral turnover in these compartments. J Virol 2003; 77: 7702-7705
    • (2003) J Virol , vol.77 , pp. 7702-7705
    • Mbori-Ngacha, D.1    Richardson, B.A.2    Overbaugh, J.3
  • 66
    • 0037040374 scopus 로고    scopus 로고
    • Changes in plasma HIV-1-RNA viral load and CD4 cell counts, and lack of zidovudine resistance among pregnant women receiving short-course zidovudine
    • Ekpini RA, Nkengasong JN, Sibailly T et al.: Changes in plasma HIV-1-RNA viral load and CD4 cell counts, and lack of zidovudine resistance among pregnant women receiving short-course zidovudine. AIDS 2002; 16: 625-630
    • (2002) AIDS , vol.16 , pp. 625-630
    • Ekpini, R.A.1    Nkengasong, J.N.2    Sibailly, T.3
  • 67
    • 0031912007 scopus 로고    scopus 로고
    • Maternal viral genotypic zidovudine resistance and infrequent failure of zidovudine therapy to prevent perinatal transmission of human immunodeficiency virus type 1 in pediatric AIDS Clinical Trials Group Protocol 076
    • Eastman PS, Shapiro DE, Coombs RW et al.: Maternal viral genotypic zidovudine resistance and infrequent failure of zidovudine therapy to prevent perinatal transmission of human immunodeficiency virus type 1 in pediatric AIDS Clinical Trials Group Protocol 076. J Infect Dis 1998; 177:557-564
    • (1998) J Infect Dis , vol.177 , pp. 557-564
    • Eastman, P.S.1    Shapiro, D.E.2    Coombs, R.W.3
  • 68
    • 0037321530 scopus 로고    scopus 로고
    • Effect of cessation of zidovudine prophylaxis to reduce vertical transmission on maternal HIV disease progression and survival
    • Bardeguez AD, Shapiro DE, Mofenson LM et al.: Effect of cessation of zidovudine prophylaxis to reduce vertical transmission on maternal HIV disease progression and survival. JAIDS 2003; 32: 170-181
    • (2003) JAIDS , vol.32 , pp. 170-181
    • Bardeguez, A.D.1    Shapiro, D.E.2    Mofenson, L.M.3
  • 69
    • 0032880154 scopus 로고    scopus 로고
    • Rapid development of genotypic resistance to lamivudine when combined with zidovudine in pregnancy
    • Clarke JR, Braganza R, Mirza A et al.: Rapid development of genotypic resistance to lamivudine when combined with zidovudine in pregnancy. J Med Virol 1999; 59:364-368
    • (1999) J Med Virol , vol.59 , pp. 364-368
    • Clarke, J.R.1    Braganza, R.2    Mirza, A.3
  • 70
    • 0027243089 scopus 로고
    • The pharmacokinetics and safety of zidovudine in the third trimester of pregnancy for women infected with human immunodeficiency virus and their infants: Phase I Acquired Immunodeficiency Syndrome Clinical Trials Group study (protocol 082)
    • O'Sullivan M, Boyer P, Scott G et al.: The pharmacokinetics and safety of zidovudine in the third trimester of pregnancy for women infected with human immunodeficiency virus and their infants: Phase I Acquired Immunodeficiency Syndrome Clinical Trials Group study (protocol 082). Am J Obstet Gynecol 1993; 168: 1510-1516
    • (1993) Am J Obstet Gynecol , vol.168 , pp. 1510-1516
    • O'Sullivan, M.1    Boyer, P.2    Scott, G.3
  • 71
    • 0033527028 scopus 로고    scopus 로고
    • Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission
    • Garcia PM, Kalish LA, Pitt J et al.: Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. N Eng J Med 1999; 341: 394-402
    • (1999) N Eng J Med , vol.341 , pp. 394-402
    • Garcia, P.M.1    Kalish, L.A.2    Pitt, J.3
  • 72
    • 0033526986 scopus 로고    scopus 로고
    • Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine
    • Mofenson LM, Lambert JS, Stiehm ER et al.: Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. N Eng J Med 1999; 341: 385-393
    • (1999) N Eng J Med , vol.341 , pp. 385-393
    • Mofenson, L.M.1    Lambert, J.S.2    Stiehm, E.R.3
  • 73
    • 0032867780 scopus 로고    scopus 로고
    • Maternal viral load and vertical transmission of HIV-1: An important factor but not the only one
    • The European Collaborative Study
    • The European Collaborative Study: Maternal viral load and vertical transmission of HIV-1: an important factor but not the only one. AIDS 1999; 13: 1377-85
    • (1999) AIDS , vol.13 , pp. 1377-1385
  • 74
    • 0033377940 scopus 로고    scopus 로고
    • Maternal virus load and perinatal human immunodeficiency virus type 1 subtype E transmission, Thailand
    • Shaffer N, Roongpisuthipong A, Siriwasin W et al.: Maternal virus load and perinatal human immunodeficiency virus type 1 subtype E transmission, Thailand. J Inf Dis 1999; 179: 590-599
    • (1999) J Inf Dis , vol.179 , pp. 590-599
    • Shaffer, N.1    Roongpisuthipong, A.2    Siriwasin, W.3
  • 76
    • 0033119011 scopus 로고    scopus 로고
    • The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1 - A meta-analysis of 15 prospective cohort studies
    • The International Perinatal HIV Group
    • The International Perinatal HIV Group: The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1 - a meta-analysis of 15 prospective cohort studies. N Eng J Med 1999; 340: 977-987
    • (1999) N Eng J Med , vol.340 , pp. 977-987
  • 77
    • 0028765439 scopus 로고
    • Recommendations of the U-S. Public Health Service Task Force on the Use of Zidovudine to Reduce Perinatal Transmission of Human Immunodeficiency Virus
    • CDC 43/RR-11
    • CDC: Recommendations of the U-S. Public Health Service Task Force on the Use of Zidovudine to Reduce Perinatal Transmission of Human Immunodeficiency Virus. MMWR 1994; 43/RR-11
    • (1994) MMWR
  • 78
    • 0034524873 scopus 로고    scopus 로고
    • An effective and safe protocol involving zidovudine and caesarean section to reduce vertical transmission of HIV-1 infection
    • Grosch-Wörner I, Schäfer A, Obladen M et al.: An effective and safe protocol involving zidovudine and caesarean section to reduce vertical transmission of HIV-1 infection. AIDS 2000; 14: 2903-2911
    • (2000) AIDS , vol.14 , pp. 2903-2911
    • Grosch-Wörner, I.1    Schäfer, A.2    Obladen, M.3
  • 79
    • 0028173861 scopus 로고
    • Cigarette smoking, premature rupture of membranes and vertical transmission of HIV1 among women with low CD4+ levels
    • Burns DN, Landesman S, Muenz LR et al.: Cigarette smoking, premature rupture of membranes and vertical transmission of HIV1 among women with low CD4+ levels. JAIDS 1994; 7: 718-726
    • (1994) JAIDS , vol.7 , pp. 718-726
    • Burns, D.N.1    Landesman, S.2    Muenz, L.R.3
  • 80
    • 0038417259 scopus 로고    scopus 로고
    • Predose infant nevirapine concentration with the two-dose intrapartum neonatal nevirapine regimen: Association with timing of maternal intrapartum nevirapine dose
    • Mirochnick M, Dorenbaum A, Blanchard S et al.: Predose infant nevirapine concentration with the two-dose intrapartum neonatal nevirapine regimen: Association with timing of maternal intrapartum nevirapine dose. JAIDS 2003; 33: 153-156
    • (2003) JAIDS , vol.33 , pp. 153-156
    • Mirochnick, M.1    Dorenbaum, A.2    Blanchard, S.3
  • 81
    • 0043129064 scopus 로고    scopus 로고
    • Timing of the maternal drug dose and risk of perinatal HIV transmission in the setting of intrapartum and neonatal single-dose nevirapine
    • Stringer JSA, Sinkala M, Chapman V et al.: Timing of the maternal drug dose and risk of perinatal HIV transmission in the setting of intrapartum and neonatal single-dose nevirapine. AIDS 2003; 17: 1659-1665
    • (2003) AIDS , vol.17 , pp. 1659-1665
    • Stringer, J.S.A.1    Sinkala, M.2    Chapman, V.3
  • 82
    • 3042848856 scopus 로고    scopus 로고
    • Nevirapine and zidovudine at birth to reduce perinatal transmission of HIV in an African setting: A randomized controlled trial
    • Taha TE, Kumwenda NI, Hoover DR et al.: Nevirapine and zidovudine at birth to reduce perinatal transmission of HIV in an African setting: a randomized controlled trial. JAMA 2004; 292(2): 202-209
    • (2004) JAMA , vol.292 , Issue.2 , pp. 202-209
    • Taha, T.E.1    Kumwenda, N.I.2    Hoover, D.R.3
  • 83
    • 3142656082 scopus 로고    scopus 로고
    • Perinatal HIV Prevention Trial (Thailand) Investigators: Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand
    • Lallemant M, Jourdain G, Le Coeur S et al. Perinatal HIV Prevention Trial (Thailand) Investigators: Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand. N Engl J Med. 2004; 351(3): 217-228
    • (2004) N Engl J Med. , vol.351 , Issue.3 , pp. 217-228
    • Lallemant, M.1    Jourdain, G.2    Le Coeur, S.3
  • 84
    • 15444365351 scopus 로고    scopus 로고
    • Field efficacy of zidovudine, lamivudine and single-dose nevirapine to prevent peripartum HIV transmission
    • ANRS 1201/1202 DITRAME PLUS Study Group
    • Dabis F, Bequet L, Ekouevi DK et al.: ANRS 1201/1202 DITRAME PLUS Study Group: Field efficacy of zidovudine, lamivudine and single-dose nevirapine to prevent peripartum HIV transmission. AIDS 2005; 19(3): 309-318.
    • (2005) AIDS , vol.19 , Issue.3 , pp. 309-318
    • Dabis, F.1    Bequet, L.2    Ekouevi, D.K.3
  • 85
    • 0038386847 scopus 로고    scopus 로고
    • Duration of ruptured membranes and extended labor are risk factors for HIV transmission
    • Garcia-Tejedor A, Perales A, Maiques V: Duration of ruptured membranes and extended labor are risk factors for HIV transmission. Int J Gynaecol Obstet. 2003; 82(1): 17-23.
    • (2003) Int J Gynaecol Obstet. , vol.82 , Issue.1 , pp. 17-23
    • Garcia-Tejedor, A.1    Perales, A.2    Maiques, V.3
  • 86
    • 33750044624 scopus 로고    scopus 로고
    • Deutsch-Österreichische Empfehlungen zur postexpositionellen Prophylaxe nach HIV-Exposition
    • (September 2004) URL
    • Deutsch-Österreichische Empfehlungen zur postexpositionellen Prophylaxe nach HIV-Exposition (September 2004) URL: http://www.rki.de
  • 87
    • 0033523454 scopus 로고    scopus 로고
    • Intrapartum and neonatal single dose nevirapine compares with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda. HIVNET 012 randomized trial
    • Guay LA, Musoke P, Fleming T et al: Intrapartum and neonatal single dose nevirapine compares with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda. HIVNET 012 randomized trial. Lancet 1999; 354: 795-802
    • (1999) Lancet , vol.354 , pp. 795-802
    • Guay, L.A.1    Musoke, P.2    Fleming, T.3
  • 88
    • 0037333802 scopus 로고    scopus 로고
    • A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1
    • Moodley D, Moodley J, Coovadia H et al.: A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1. J Infect Dis 2003; 187: 725-735
    • (2003) J Infect Dis , vol.187 , pp. 725-735
    • Moodley, D.1    Moodley, J.2    Coovadia, H.3
  • 89
    • 20844437104 scopus 로고    scopus 로고
    • Sensitive drug-resistance assays reveal long-term persistence of HIV-1 variants with the K103N nevirapine (NVP) resistance mutation in some women and infants after the administration of single-dose NVP: HIVNET 012
    • Flys T, Nissley DV, Claasen CW et al.: Sensitive drug-resistance assays reveal long-term persistence of HIV-1 variants with the K103N nevirapine (NVP) resistance mutation in some women and infants after the administration of single-dose NVP: HIVNET 012. J Infect Dis 2005; 192(1): 24-29
    • (2005) J Infect Dis , vol.192 , Issue.1 , pp. 24-29
    • Flys, T.1    Nissley, D.V.2    Claasen, C.W.3
  • 92
    • 0035865870 scopus 로고    scopus 로고
    • CM: Perinatal transmission of human immunodeficiency virus type 1 by pregnant women with RNA virus loads <1000copies/ml
    • Ioannidis JPA, Abrams EJ, Ammann A et al.: CM: Perinatal transmission of human immunodeficiency virus type 1 by pregnant women with RNA virus loads <1000copies/ml. J Inf Dis 2001; 183: 539-545
    • (2001) J Inf Dis , vol.183 , pp. 539-545
    • Ioannidis, J.P.A.1    Abrams, E.J.2    Ammann, A.3
  • 93
    • 0032753022 scopus 로고    scopus 로고
    • Frequent detection of HIV-1 in the gastric aspirates of neonates born to HIV-infected mothers
    • Mandelbrot L, Burgard M, Teglas J-P et al.: Frequent detection of HIV-1 in the gastric aspirates of neonates born to HIV-infected mothers. AIDS 1999; 13: 2143-2149
    • (1999) AIDS , vol.13 , pp. 2143-2149
    • Mandelbrot, L.1    Burgard, M.2    Teglas, J.-P.3
  • 94
    • 0035082926 scopus 로고    scopus 로고
    • Viral excretion in cervicovaginal secretions of HIV-1-infected women receiving antiretroviral therapy
    • Debiaggi M, Zara F, Spinillo A et al.: Viral excretion in cervicovaginal secretions of HIV-1-infected women receiving antiretroviral therapy. Eur J Microbiol Infect Dis 2001; 20: 91-96
    • (2001) Eur J Microbiol Infect Dis , vol.20 , pp. 91-96
    • Debiaggi, M.1    Zara, F.2    Spinillo, A.3
  • 95
    • 0035400159 scopus 로고    scopus 로고
    • Cellular replication of human immunodeficiency virus type 1 occurs in vaginal secretions
    • Ellerbrock TV, Lennox JL, Clancy KA et al.: Cellular replication of human immunodeficiency virus type 1 occurs in vaginal secretions. J Infect Dis 2001, 184: 28-36
    • (2001) J Infect Dis , vol.184 , pp. 28-36
    • Ellerbrock, T.V.1    Lennox, J.L.2    Clancy, K.A.3
  • 96
    • 0033914449 scopus 로고    scopus 로고
    • Selection of drug-resistant variants in the female genital tract of human immunodeficiency virus type 1-infected women receiving antiretroviral therapy
    • Si-Mohamed A, Kazatchkine MD, Goujon C et al.: Selection of drug-resistant variants in the female genital tract of human immunodeficiency virus type 1-infected women receiving antiretroviral therapy. J Infect Dis 2000, 182: 112-122
    • (2000) J Infect Dis , vol.182 , pp. 112-122
    • Si-Mohamed, A.1    Kazatchkine, M.D.2    Goujon, C.3
  • 97
    • 0036329526 scopus 로고    scopus 로고
    • Low complication rate associated with cesarean section under spinal anesthesia for HIV-1-infected women on antiretroviral therapy
    • Avidan MS, Groves P, Blott M et al.: Low complication rate associated with cesarean section under spinal anesthesia for HIV-1-infected women on antiretroviral therapy. Anesthesiology 2002; 97(2): 320-324
    • (2002) Anesthesiology , vol.97 , Issue.2 , pp. 320-324
    • Avidan, M.S.1    Groves, P.2    Blott, M.3
  • 98
    • 0035280934 scopus 로고    scopus 로고
    • Mode of delivery and postpartum morbidity among HIV-infected women: The women and infants transmission study
    • Read J, Tuomala R, Kpamegan E et al.: Mode of delivery and postpartum morbidity among HIV-infected women: the women and infants transmission study. JAIDS 2001; 26: 236-245
    • (2001) JAIDS , vol.26 , pp. 236-245
    • Read, J.1    Tuomala, R.2    Kpamegan, E.3
  • 99
    • 0035340096 scopus 로고    scopus 로고
    • Postoperative morbidity associated with cesarean delivery among human immunodeficiency virus-seropositive women
    • Rodriguez EJ, Spann C, Jamieson D et al.: Postoperative morbidity associated with cesarean delivery among human immunodeficiency virus-seropositive women. Am J Obstet Gynecol 2001, 184:1108-1111
    • (2001) Am J Obstet Gynecol , vol.184 , pp. 1108-1111
    • Rodriguez, E.J.1    Spann, C.2    Jamieson, D.3
  • 100
    • 0033869318 scopus 로고    scopus 로고
    • Complications according to mode of delivery among human immunodeficiency virus-infected women with CD4 lymphocyte counts of < or = 500/microL
    • Watts DH, Lambert JS, Stiehm ER et al.: Complications according to mode of delivery among human immunodeficiency virus-infected women with CD4 lymphocyte counts of < or = 500/microL. Am J Obstet Gynecol 2000; 183:100-107
    • (2000) Am J Obstet Gynecol , vol.183 , pp. 100-107
    • Watts, D.H.1    Lambert, J.S.2    Stiehm, E.R.3
  • 101
    • 0034526376 scopus 로고    scopus 로고
    • Combination antiretroviral therapy and duration of pregnancy
    • European Collaborative Study and the Swiss Mother + Child HIV Cohort Study
    • European Collaborative Study and the Swiss Mother + Child HIV Cohort Study: Combination antiretroviral therapy and duration of pregnancy. AIDS 2000; 14: 2913-2920
    • (2000) AIDS , vol.14 , pp. 2913-2920
  • 102
    • 0034161409 scopus 로고    scopus 로고
    • Effect of breastfeeding and formula feeding on Transmission of HIV-1
    • Nduati R, John G, Mbori-Ngacha D et al.: Effect of breastfeeding and formula feeding on Transmission of HIV-1. JAMA 2000; 283: 1167-1174
    • (2000) JAMA , vol.283 , pp. 1167-1174
    • Nduati, R.1    John, G.2    Mbori-Ngacha, D.3
  • 103
    • 0032953964 scopus 로고    scopus 로고
    • Transmission of human immunodeficiency virus type 1 through breast-feeding: How can it be prevented?
    • Van de Perre P.: Transmission of human immunodeficiency virus type 1 through breast-feeding: how can it be prevented? J Infect Dis. 1999; 179 Suppl 3: S405-407
    • (1999) J Infect Dis. , vol.179 , Issue.SUPPL. 3
    • Van de Perre, P.1
  • 104
    • 0028862260 scopus 로고
    • Human immunodeficiency virus type 1 infected cells in breast milk
    • Nduati RW, John GC, Richardson BA et al.: Human immunodeficiency virus type 1 infected cells in breast milk. Infect Dis 1995; 172: 1461-1468
    • (1995) Infect Dis , vol.172 , pp. 1461-1468
    • Nduati, R.W.1    John, G.C.2    Richardson, B.A.3
  • 105
    • 0022349942 scopus 로고
    • Isolation of AIDS virus from cell-free breastmilk of three healthy virus carriers
    • Thiry L, Spencer-Goldberger S, Jonckheer T et al.: Isolation of AIDS virus from cell-free breastmilk of three healthy virus carriers. Lancet 1985 ii: 891-892
    • (1985) Lancet , vol.2 , pp. 891-892
    • Thiry, L.1    Spencer-Goldberger, S.2    Jonckheer, T.3
  • 106
    • 85046113809 scopus 로고    scopus 로고
    • False-negative polymerase chain reaction-based diagnosis of human immunodeficiency virus type 1 in children infected with HIV strains of African origin
    • Haas J, Geiss M, Böhler T et al.: False-negative polymerase chain reaction-based diagnosis of human immunodeficiency virus type 1 in children infected with HIV strains of African origin. J Infect Dis 1996; 174: 224-225
    • (1996) J Infect Dis , vol.174 , pp. 224-225
    • Haas, J.1    Geiss, M.2    Böhler, T.3
  • 107
    • 0343317894 scopus 로고
    • Early diagnosis of HIV infection in infants - Report of a consensus
    • workshop Siena, Italy, January 17-18, 1992
    • Rossi P, et al.: Early diagnosis of HIV infection in infants - Report of a consensus workshop, Siena, Italy, January 17-18, 1992. JAIDS 1992; 5: 1168-1178
    • (1992) JAIDS , vol.5 , pp. 1168-1178
    • Rossi, P.1
  • 108
    • 0032540034 scopus 로고    scopus 로고
    • Guidelines for the use of antiretroviral agents in pediatric HIV infection
    • CENTERS OF DISEASE CONTROL URL
    • CENTERS OF DISEASE CONTROL: Guidelines for the use of antiretroviral agents in pediatric HIV infection. MMWR 1998; 47: 1-43; URL http:// www.hivatis.org
    • (1998) MMWR , vol.47 , pp. 1-43
  • 109
    • 0037238447 scopus 로고    scopus 로고
    • Pediatric AIDS Clinical Trials Group 331 Investigators: Pharmacokinetics and tolerance of zidovudine in preterm infants
    • Capparelli EV, Mirochnick M, Dankner WM et al.: Pediatric AIDS Clinical Trials Group 331 Investigators: Pharmacokinetics and tolerance of zidovudine in preterm infants. J Pediatr 2003; 142(1): 47- 52
    • (2003) J Pediatr , vol.142 , Issue.1 , pp. 47-52
    • Capparelli, E.V.1    Mirochnick, M.2    Dankner, W.M.3
  • 110
    • 0037716608 scopus 로고    scopus 로고
    • HlV detection in amniotic fluid samples. Amniocentesis can be performed in HIV pregnant women?
    • Maiques V, Garcia-Tejedor A, Perales A et al: HlV detection in amniotic fluid samples. Amniocentesis can be performed in HIV pregnant women? Eur J Obstet Gynecol Reprod Biol 2003; 108(2): 137-141
    • (2003) Eur J Obstet Gynecol Reprod Biol , vol.108 , Issue.2 , pp. 137-141
    • Maiques, V.1    Garcia-Tejedor, A.2    Perales, A.3
  • 111
    • 0037313784 scopus 로고    scopus 로고
    • Society of Obstetricians and Gynaecologists of Canada: Amniocentesis and women with hepatitis B, hepatitis C or human immunodeficiency virus
    • 149-152
    • Davies G, Wilson RD, Desilets V et al.: Society of Obstetricians and Gynaecologists of Canada: Amniocentesis and women with hepatitis B, hepatitis C or human immunodeficiency virus. J Obstet Gynaecol Can 2003; 25(2): 145-148, 149-152
    • (2003) J Obstet Gynaecol Can , vol.25 , Issue.2 , pp. 145-148
    • Davies, G.1    Wilson, R.D.2    Desilets, V.3
  • 112
    • 4143074797 scopus 로고    scopus 로고
    • Perinatal genotoxicity and carcinogenicity of anti-retroviral nucleoside analog drugs
    • Poirier MC, Olivero CA, Walker DM et al.: Perinatal genotoxicity and carcinogenicity of anti-retroviral nucleoside analog drugs. Toxicol Appl Pharmacol 2004; 199(2): 151-161
    • (2004) Toxicol Appl Pharmacol , vol.199 , Issue.2 , pp. 151-161
    • Poirier, M.C.1    Olivero, C.A.2    Walker, D.M.3
  • 113
    • 10944246142 scopus 로고    scopus 로고
    • Pharmacokinetics of antiretrovirals in pregnant women
    • Mirochnick M, Capparelli E et al.: Pharmacokinetics of antiretrovirals in pregnant women. Clin Pharmacokinet 2004; 43(15): 1071-1087
    • (2004) Clin Pharmacokinet , vol.43 , Issue.15 , pp. 1071-1087
    • Mirochnick, M.1    Capparelli, E.2
  • 114
    • 12144252054 scopus 로고    scopus 로고
    • Emergence of antiretroviral resistance in HIV-positive women receiving combination antiretroviral therapy in pregnancy
    • Lyons FE, Coughlan S, Byrne CM et al.: Emergence of antiretroviral resistance in HIV-positive women receiving combination antiretroviral therapy in pregnancy. AIDS 2005; 19(1): 63-67
    • (2005) AIDS , vol.19 , Issue.1 , pp. 63-67
    • Lyons, F.E.1    Coughlan, S.2    Byrne, C.M.3
  • 115
    • 0036603048 scopus 로고    scopus 로고
    • Antiretroviral prophylaxis of perinatal HIV-1 transmission and the potential impact of antiretroviral resistance
    • Review
    • Nolan M, Fowler MG, Molenson LM. Antiretroviral prophylaxis of perinatal HIV-1 transmission and the potential impact of antiretroviral resistance. J Acquir Immune Defic Syndr. 2002; 30(2): 216-29. Review
    • (2002) J Acquir Immune Defic Syndr. , vol.30 , Issue.2 , pp. 216-229
    • Nolan, M.1    Fowler, M.G.2    Molenson, L.M.3
  • 116
    • 10244236453 scopus 로고    scopus 로고
    • Increased risk of adverse pregnancy outcomes in HIV-infected women treated with highly active antiretroviral therapy in Europe
    • Thorne C, Patel D, Newell ML: Increased risk of adverse pregnancy outcomes in HIV-infected women treated with highly active antiretroviral therapy in Europe. AIDS 2004; 18(17): 2337-2339
    • (2004) AIDS , vol.18 , Issue.17 , pp. 2337-2339
    • Thorne, C.1    Patel, D.2    Newell, M.L.3
  • 117
    • 2142817146 scopus 로고    scopus 로고
    • Higher rates of post-partum complications in HIV-infected than in uninfected women irrespective of mode of delivery
    • European HIV in Obstetrics Group
    • Fiore S, Newell ML, Thorne C: European HIV in Obstetrics Group: Higher rates of post-partum complications in HIV-infected than in uninfected women irrespective of mode of delivery. AIDS 2004; 18(6): 933-938
    • (2004) AIDS , vol.18 , Issue.6 , pp. 933-938
    • Fiore, S.1    Newell, M.L.2    Thorne, C.3
  • 118
    • 0036264320 scopus 로고    scopus 로고
    • Differences in postpartum morbidity in women who are infected with the human immunodeficiency virus after elective cesarean delivery, emergency cesarean delivery, or vaginal delivery
    • Marcollet A, Goffinet F, Firtion G et al: Differences in postpartum morbidity in women who are infected with the human immunodeficiency virus after elective cesarean delivery, emergency cesarean delivery, or vaginal delivery. Am J Obstet Gynecol 2002; 186(4): 784-789
    • (2002) Am J Obstet Gynecol , vol.186 , Issue.4 , pp. 784-789
    • Marcollet, A.1    Goffinet, F.2    Firtion, G.3
  • 119
    • 0035841613 scopus 로고    scopus 로고
    • Determinants of HIV-1 shedding in the genital tract of women
    • DATRI Study Group; WIHS Study Group
    • Kovacs A, Wasserman SS, Burns D et al.: DATRI Study Group; WIHS Study Group: Determinants of HIV-1 shedding in the genital tract of women. Lancet 2001; 358(9293): 1593-1601
    • (2001) Lancet , vol.358 , Issue.9293 , pp. 1593-1601
    • Kovacs, A.1    Wasserman, S.S.2    Burns, D.3
  • 120
    • 10744231331 scopus 로고    scopus 로고
    • Correlates of HIV-1 shedding in cervicovaginal secretions and effects of antiretroviral therapies
    • Fiore JR, Suligoi B, Saracino A et al.: Correlates of HIV-1 shedding in cervicovaginal secretions and effects of antiretroviral therapies. AIDS 2003; 17(15): 2169-2176
    • (2003) AIDS , vol.17 , Issue.15 , pp. 2169-2176
    • Fiore, J.R.1    Suligoi, B.2    Saracino, A.3
  • 121
    • 0037314746 scopus 로고    scopus 로고
    • Cell-associated genital tract virus and vertical transmission of human immunodeficiency virus type 1 in antiretroviral-experienced women
    • Women and Infants Transmission Study
    • Tuomala RE, O'Driscoll PT, Bremer JW et al.: Women and Infants Transmission Study: Cell-associated genital tract virus and vertical transmission of human immunodeficiency virus type 1 in antiretroviral-experienced women. J Infect Dis 2003; 187(3): 375-384
    • (2003) J Infect Dis , vol.187 , Issue.3 , pp. 375-384
    • Tuomala, R.E.1    O'Driscoll, P.T.2    Bremer, J.W.3
  • 122
    • 23344448564 scopus 로고    scopus 로고
    • Addition of 3 Days of ZDV+3TC Postpartum to a Short Course of ZDV+3TC and Single-dose NVP Provides Low Rate of NVP Resistance Mutations and High Efficacy in Preventing Peri-partum HIV-1 Transmission: ANRS DITRAME Plus, Abidjan, Côte d'Ivoire
    • 12th CROI, Boston Abstr. 72LB
    • Chaix ML, Dabis F, Ekouevi D et al.: Addition of 3 Days of ZDV+3TC Postpartum to a Short Course of ZDV+3TC and Single-dose NVP Provides Low Rate of NVP Resistance Mutations and High Efficacy in Preventing Peri-partum HIV-1 Transmission: ANRS DITRAME Plus, Abidjan, Côte d'Ivoire. 12th CROI, Boston 2005, Abstr. 72LB
    • (2005)
    • Chaix, M.L.1    Dabis, F.2    Ekouevi, D.3
  • 123
    • 0033526986 scopus 로고    scopus 로고
    • Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine
    • Pediatric AIDS Clinical Trials Group Study 185 Team
    • Mofenson LM, Lambert JS, Stiehm ER et al.: Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team. N Engl J Med. 1999; 341(6): 385-393
    • (1999) N Engl J Med. , vol.341 , Issue.6 , pp. 385-393
    • Mofenson, L.M.1    Lambert, J.S.2    Stiehm, E.R.3
  • 124
    • 0033604573 scopus 로고    scopus 로고
    • Maternal viral load and the risk of perinatal transmission of HIV-1
    • Ioannidis JP, Contopoulos-Ioannidis DG: Maternal viral load and the risk of perinatal transmission of HIV-1. N Engl J Med. 1999; 341(22): 1698-1700
    • (1999) N Engl J Med. , vol.341 , Issue.22 , pp. 1698-1700
    • Ioannidis, J.P.1    Contopoulos-Ioannidis, D.G.2
  • 125
    • 4444287093 scopus 로고    scopus 로고
    • Maternal-fetal transfer and amniotic fluid accumulation of protease inhibitors in pregnant women who are infected with human immunodeficiency virus
    • Chappuy H, Treluyer JM, Rey E et al.: Maternal-fetal transfer and amniotic fluid accumulation of protease inhibitors in pregnant women who are infected with human immunodeficiency virus. Am J Obstet Gynecol. 2004; 191(2): 558-562
    • (2004) Am J Obstet Gynecol. , vol.191 , Issue.2 , pp. 558-562
    • Chappuy, H.1    Treluyer, J.M.2    Rey, E.3
  • 126
  • 127
    • 4744362280 scopus 로고    scopus 로고
    • Enfuvirtide prescription at the end of pregnancy to a multi-treated HIV-infected woman with virological breakthrough
    • Meyohas MC, Lacombe K, Carbonne B et al.: Enfuvirtide prescription at the end of pregnancy to a multi-treated HIV-infected woman with virological breakthrough. AIDS 2004; 18(14): 1966-1968
    • (2004) AIDS , vol.18 , Issue.14 , pp. 1966-1968
    • Meyohas, M.C.1    Lacombe, K.2    Carbonne, B.3
  • 129
    • 0028794926 scopus 로고
    • The sensitivity of HIV1-DNA polymerase chain reaction in the neonatal period and the relative contributions of intra-uterine and intra-partum transmission
    • Dunn DT, Brandt CD, Kirvine A et al.: The sensitivity of HIV1-DNA polymerase chain reaction in the neonatal period and the relative contributions of intra-uterine and intra-partum transmission. AIDS 1995; 9(9): F7-11
    • (1995) AIDS , vol.9 , Issue.9
    • Dunn, D.T.1    Brandt, C.D.2    Kirvine, A.3
  • 130
    • 0036904870 scopus 로고    scopus 로고
    • Short-course therapy with zidovudine plus lamivudine for prevention of mother-to-child transmission of human immunodeficiency virus type 1 in Thailand
    • Chaisilwattana P, Chokephaibulkit K, Chalermchockcharoenkit A et al.: Short-course therapy with zidovudine plus lamivudine for prevention of mother-to-child transmission of human immunodeficiency virus type 1 in Thailand. Clin Infect Dis 2002 35(11): 1405-1413
    • (2002) Clin Infect Dis , vol.35 , Issue.11 , pp. 1405-1413
    • Chaisilwattana, P.1    Chokephaibulkit, K.2    Chalermchockcharoenkit, A.3
  • 131
    • 0035853373 scopus 로고    scopus 로고
    • HIV-infected pregnant women and vertical transmission in Europe since 1986
    • European collaborative study
    • European collaborative study. HIV-infected pregnant women and vertical transmission in Europe since 1986. AIDS. 2001 15(6): 761-770
    • (2001) AIDS , vol.15 , Issue.6 , pp. 761-770
  • 132
    • 13444300922 scopus 로고    scopus 로고
    • Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy
    • European Collaborative Study
    • European Collaborative Study. Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy. Clin Infect Dis 2005 40(3): 458-465
    • (2005) Clin Infect Dis , vol.40 , Issue.3 , pp. 458-465
  • 133
    • 23244437092 scopus 로고    scopus 로고
    • Highly active antiretroviral therapy (HAARI) retreatment in patients on CD4-guided therapy achieved similar virologic suppression compared with patients on continuous HAART: The HIV Netherlands Australia Thailand Research Collaboration 001.4 study
    • Ananworanich J, Siangphoe U, Hill A et al.: Highly active antiretroviral therapy (HAARI) retreatment in patients on CD4-guided therapy achieved similar virologic suppression compared with patients on continuous HAART: the HIV Netherlands Australia Thailand Research Collaboration 001.4 study. JAIDS 2005; 39(5): 523-529
    • (2005) JAIDS , vol.39 , Issue.5 , pp. 523-529
    • Ananworanich, J.1    Siangphoe, U.2    Hill, A.3
  • 134
    • 24644469032 scopus 로고    scopus 로고
    • Can highly active antiretroviral therapy be interrupted in patients with sustained moderate HIV RNA and > 400 CD4(+) cells/microl? Impact on immunovirological parameters
    • Pellegrin I, Thiebaut R, Blanco P et al.: Can highly active antiretroviral therapy be interrupted in patients with sustained moderate HIV RNA and > 400 CD4(+) cells/microl? Impact on immunovirological parameters. J Med Virol 2005; 77(2): 164-172
    • (2005) J Med Virol , vol.77 , Issue.2 , pp. 164-172
    • Pellegrin, I.1    Thiebaut, R.2    Blanco, P.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.